• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis, Inc. - Common Stock (NQ:PSNL)

    16.16 -0.16 (-0.98%)
    Streaming Delayed Price Updated: 11:13 AM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 285,078
    Open 16.25
    Bid (Size) 16.15 (200)
    Ask (Size) 16.17 (600)
    Prev. Close 16.32
    Today's Range 16.08 - 16.47
    52wk Range 4.955 - 18.89
    Shares Outstanding 48,518,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Halper Sadeh LLC is Investigating Whether CSR, FULC, WEAV, PSNL are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL)
    From Brodsky & Smith LLC
    Via GlobeNewswire

    Performance

    YTD
    +105.9%
    +105.9%
    1 Month
    -3.7%
    -3.7%
    3 Month
    +17.5%
    +17.5%
    6 Month
    +159.0%
    +159.0%
    1 Year
    +154.5%
    +154.5%

    More News

    Read More
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether UTZ, PSNL, DSGR are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Personalis Reports Second Quarter Results and Recent Highlights
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Halper Sadeh LLC is Investigating Whether UTZ, BLFS, FNWD, PSNL are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether FNWD and PSNL are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether LXP, FNWD, PSNL are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Luxfer Holdings PLC (NYSE – LXFR), Finward Bancorp (Nasdaq – FNWD), Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether UTZ, PSNL, LXP are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    PSNL Stock Alert: Halper Sadeh LLC is Investigating Whether Personalis, Inc. is Obtaining a Fair Price for Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in Upcoming Investor Events
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Personalis (PSNL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Personalis, Inc. - Common Stock publicly traded?
    Yes, Personalis, Inc. - Common Stock is publicly traded.
    What exchange does Personalis, Inc. - Common Stock trade on?
    Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Personalis, Inc. - Common Stock?
    The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
    What is the current price of Personalis, Inc. - Common Stock?
    The current price of Personalis, Inc. - Common Stock is 16.16
    When was Personalis, Inc. - Common Stock last traded?
    The last trade of Personalis, Inc. - Common Stock was at 09/29/26 11:13 AM ET
    What is the market capitalization of Personalis, Inc. - Common Stock?
    The market capitalization of Personalis, Inc. - Common Stock is 784.07M
    How many shares of Personalis, Inc. - Common Stock are outstanding?
    Personalis, Inc. - Common Stock has 784M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.